English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/142813
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Correction: Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications

AuthorsAmaral, Ana Teresa; Biscuola, Michele; López-García, María Ángeles; Álava, Enrique de
Issue Date3-Apr-2014
PublisherPublic Library of Science
CitationPLoS ONE 9(4): e94455 (2014)
Abstract[Background] Ewing Sarcoma (EWS) is a mesenchymal-derived tumor that generally arises in bone and soft tissue. Intensive research regarding the pathogenesis of EWS has been insufficient to pinpoint the early events of Ewing sarcomagenesis. However, the Mesenchymal Stem Cell (MSC) is currently accepted as the most probable cell of origin.
[Materials and Methods] In an initial study regarding a deep characterization of MSC obtained specifically from EWS patients (MSC-P), we compared them with MSC derived from healthy donors (MSC-HD) and EWS cell lines. We evaluated the presence of the EWS-FLI1 gene fusion and EWSR1 gene rearrangements in MSC-P. The presence of the EWS transcript was confirmed by q-RT-PCR. In order to determine early events possibly involved in malignant transformation, we used a multiparameter quantitative strategy that included both MSC immunophenotypic negative/positive markers, and EWS intrinsic phenotypical features. Markers CD105, CD90, CD34 and CD45 were confirmed in EWS samples.
[Results] We determined that MSC-P lack the most prevalent gene fusion, EWSR1-FLI1 as well as EWSR1 gene rearrangements. Our study also revealed that MSC-P are more alike to MSC-HD than to EWS cells. Nonetheless, we also observed that EWS cells had a few overlapping features with MSC. As a relevant example, also MSC showed CD99 expression, hallmark of EWS diagnosis. However, we observed that, in contrast to EWS cells, MSC were not sensitive to the inhibition of CD99.
[Conclusions] In conclusion, our results suggest that MSC from EWS patients behave like MSC-HD and are phenotypically different from EWS cells, thus raising important questions regarding MSC role in sarcomagenesis. © 2014 Amaral et al.
DescriptionAmaral, Ana Teresa et al.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pone.0094455
URIhttp://hdl.handle.net/10261/142813
DOI10.1371/journal.pone.0094455
ISSN1932-6203
ReferencesAmaral, Ana Teresa; Biscuola, Michele; López-García, María Ángeles; Álava, Enrique de. Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications. http://doi.org/10.1371/journal.pone.0085814 . http://hdl.handle.net/10261/142805
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
Correction_human_mesenchymal_stem_cells_Amaral.pdf137,97 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.